Interventional oncology turns a profit for radiology groups

Article

Although the infrastructure required to provide image-guided therapies to treat cancer is costly, interventional oncology practices can provide radiology departments with generous revenue, according to University of Pennsylvania researchers.

Although the infrastructure required to provide image-guided therapies to treat cancer is costly, interventional oncology practices can provide radiology departments with generous revenue, according to University of Pennsylvania researchers.

Dr. Catherine Tuite and colleagues reviewed data from 1999 to 2003 for 68 patients who underwent radiofrequency ablation of liver tumors at their outpatient interventional radiology clinic.

They found that the clinic provided substantial incremental income to the general radiology practice. They presented the findings at the 2005 meeting of the Society of Interventional Radiology.

The research team included financial and marketing analysts. It recorded all aspects involved with the workup of interventional oncology patients: initial consultation, diagnostic imaging, intervention, and follow-up.

Interventional radiologists performed 100 ablations with an average professional billing of $976.77 each. Follow-up imaging included MR, CT, and plain-film radiography.

Subsequent analysis of relative value units drawn against standard payment rates from the Centers for Medicare and Medicaid Services provided the department with a total professional revenue of $7000 and $10,000 per each new ablation and chemoembolization patient, respectively.

The average revenue to the radiology practice came to above $120,000 annually, said coauthor Dr. Michael C. Soulen.

"When RFA first came out in the late 1990s, we treated about six patients with liver cancer per year. Now we treat from two to six patients per day with all interventional oncology procedures," Soulen said.

For more information from the Diagnostic Imaging archives:

Nonsurgical therapies mitigate pain from bone tumors

Lung RFA's midterm survival rates beat expectations

Insurance companies line up to reimburse for liver RFA

RF tumor ablation breaks through in clinical practice

Recent Videos
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Related Content
© 2025 MJH Life Sciences

All rights reserved.